No overdiagnosis of ADHD, say experts
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.
GE HealthCare announced that View has received 510(k) clearance from the FDA. Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis… read more.
A simple 5-minute test addressing major endometriosis diagnostic delays and treatment, has been developed by University of Queensland researchers. The Simplified Adolescent Factors for Endometriosis (SAFE) score uses… read more.
Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly, yearly deaths… read more.
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day… read more.
A global atlas mapping two key gut bacteria in infants around the world has uncovered a treasure trove of bacterial strains adapted to the infant gut and not… read more.
Researchers report that patients diagnosed with cancer who subsequently develop a mental disorder are at an increased risk of all-cause death. The findings were published on Feb. 23,… read more.
PTC Therapeutics Inc. announced that it has withdrawn the New Drug Application (NDA) resubmission for Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (DMD) following… read more.
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools. While experts hope this will increase uptake in the under-screened population, a… read more.
Zevra Therapeutics announced the presentation of four posters highlighting positive new data on Miplyffa (arimoclomol) for the treatment of Niemann-Pick Disease Type C (NPC) at the 22nd Annual… read more.
Health Canada has issued a Notice of Compliance with conditions (NOC/c) for Voxzogo (vosoritide for injection) a modified recombinant human C-type natriuretic peptide 39 (CNP-39) for the treatment… read more.
Scientists have discovered a biomarker that could be used to identify Parkinson’s before extensive brain damage has occurred. The finding, by a team at Chalmers University of Technology,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.